Evidence map›Paper›PMID 34025352›Full record

ArticleFrontiers in molecular neuroscience2021

Beyond Neuronal Microtubule Stabilization: MAP6 and CRMPS, Two Converging Stories.

Camille Cuveillier, Benoit Boulan, Charlotte Ravanello, Eric Denarier, Jean-Christophe Deloulme, Sylvie Gory-Fauré, Christian Delphin, Christophe Bosc, Isabelle Arnal, Annie Andrieux

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Proper localization of the SCA13-linked KNeurobiology of disease · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Neurons as a model system for cryo-electron tomography.Journal of structural biology: X · 2022
    Article
  15. The 14-3-3 Protein Family and Schizophrenia.Frontiers in molecular neuroscience · 2022
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Camille CuveillierUniv. Grenoble Alpes, Inserm U1216, CEA-IRIG, CNRS, Grenoble Institut Neurosciences, Grenoble, France.
Benoit BoulanUniv. Grenoble Alpes, Inserm U1216, CEA-IRIG, CNRS, Grenoble Institut Neurosciences, Grenoble, France.
Charlotte RavanelloUniv. Grenoble Alpes, Inserm U1216, CEA-IRIG, CNRS, Grenoble Institut Neurosciences, Grenoble, France.
Eric DenarierUniv. Grenoble Alpes, Inserm U1216, CEA-IRIG, CNRS, Grenoble Institut Neurosciences, Grenoble, France.
Jean-Christophe DeloulmeUniv. Grenoble Alpes, Inserm U1216, CEA-IRIG, CNRS, Grenoble Institut Neurosciences, Grenoble, France.
Sylvie Gory-FauréUniv. Grenoble Alpes, Inserm U1216, CEA-IRIG, CNRS, Grenoble Institut Neurosciences, Grenoble, France.
Christian DelphinUniv. Grenoble Alpes, Inserm U1216, CEA-IRIG, CNRS, Grenoble Institut Neurosciences, Grenoble, France.
Christophe BoscUniv. Grenoble Alpes, Inserm U1216, CEA-IRIG, CNRS, Grenoble Institut Neurosciences, Grenoble, France.
Isabelle ArnalUniv. Grenoble Alpes, Inserm U1216, CEA-IRIG, CNRS, Grenoble Institut Neurosciences, Grenoble, France.
Annie AndrieuxUniv. Grenoble Alpes, Inserm U1216, CEA-IRIG, CNRS, Grenoble Institut Neurosciences, Grenoble, France.
Inserm · FRUniversité Grenoble Alpes · FRCEA Grenoble · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development and function of the central nervous system rely on the microtubule (MT) and actin cytoskeletons and their respective effectors. Although the structural role of the cytoskeleton has long been acknowledged in neuronal morphology and activity, it was recently recognized to play the role of a signaling platform. Following this recognition, research into Microtubule Associated Proteins (MAPs) diversified. Indeed, historically, structural MAPs-including MAP1B, MAP2, Tau, and MAP6 (also known as STOP);-were identified and described as MT-binding and -stabilizing proteins. Extensive data obtained over the last 20 years indicated that these structural MAPs could also contribute to a variety of other molecular roles. Among multi-role MAPs, MAP6 provides a striking example illustrating the diverse molecular and cellular properties of MAPs and showing how their functional versatility contributes to the central nervous system. In this review, in addition to MAP6's effect on microtubules, we describe its impact on the actin cytoskeleton, on neuroreceptor homeostasis, and its involvement in signaling pathways governing neuron development and maturation. We also discuss its roles in synaptic plasticity, brain connectivity, and cognitive abilities, as well as the potential relationships between the integrated brain functions of MAP6 and its molecular activities. In parallel, the Collapsin Response Mediator Proteins (CRMPs) are presented as examples of how other proteins, not initially identified as MAPs, fall into the broader MAP family. These proteins bind MTs as well as exhibiting molecular and cellular properties very similar to MAP6. Finally, we briefly summarize the multiple similarities between other classical structural MAPs and MAP6 or CRMPs.In summary, this review revisits the molecular properties and the cellular and neuronal roles of the classical MAPs, broadening our definition of what constitutes a MAP.

Indexed as

actincognitionmicrotubulemicrotubule-associated-proteinsneuronpsychiatric diseasesynapse

Identifiers

PMID34025352
PMCPMC8131560
OpenAlexW3158248085

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.